The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
The World Health Organization’s universal health coverage (UHC) initiative, plus the expansion of health insurance in Africa are explored here by Open Access Government
Simone Boselli, Public Affairs Director of EURORDIS shares the fascinating findings of a new position paper that offers a synthesis of their analysis, reflections and perspectives on access to rare disease therapies in Europe today
The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government
Open Access Government details the work of the National Toxicology Program, a world leader in providing scientific information to help evaluate and better understand the potential health effects of exposure to chemicals and other substances
Distributed and open technologies are bringing new business models, personalisation, prediction, motivation, collaboration and trust in healthcare, in the view of Sari Stenfors from the ReCon Blockchain Research Project, at Aalto University in Finland
A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna
Greg Rosenthal of the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service explains how right-sizing regulation can optimise plant protection
Dr Olga V Volpert’s work on sunlight-induced carcinogenesis at the MD Anderson Cancer Center is explored here, including why angiogenesis is critically important in skin cancer progression
The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government
Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida
